Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journey

Matteo Lambertini, Christian Jackisch, Olivier Trédan, Maria Vidal, Mário Fontes-Sousa, Antonios Valachis, Rosanna D’Antona, Marcelo Ruz, Eugenia Krone, Miriam Brice, Erwan Berjonneau, Soraia Matos, Olivia Dialla, Laure Guéroult-Accolas

Open source

DOI: 10.1080/14796694.2026.2666390
Published: 2026-05-13
Container: Future Oncology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2666390,
  title = {Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journey},
  author = {Matteo Lambertini and Christian Jackisch and Olivier Trédan and Maria Vidal and Mário Fontes-Sousa and Antonios Valachis and Rosanna D’Antona and Marcelo Ruz and Eugenia Krone and Miriam Brice and Erwan Berjonneau and Soraia Matos and Olivia Dialla and Laure Guéroult-Accolas},
  year = {2026},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2026.2666390},
  url = {https://doi.org/10.1080/14796694.2026.2666390}
}

RIS

TY  - JOUR
TI  - Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journey
AU  - Matteo Lambertini
AU  - Christian Jackisch
AU  - Olivier Trédan
AU  - Maria Vidal
AU  - Mário Fontes-Sousa
AU  - Antonios Valachis
AU  - Rosanna D’Antona
AU  - Marcelo Ruz
AU  - Eugenia Krone
AU  - Miriam Brice
AU  - Erwan Berjonneau
AU  - Soraia Matos
AU  - Olivia Dialla
AU  - Laure Guéroult-Accolas
PY  - 2026
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2666390
UR  - https://doi.org/10.1080/14796694.2026.2666390
ER  -

APA

Lambertini, M., Jackisch, C., Trédan, O., Vidal, M., Fontes-Sousa, M., Valachis, A., D’Antona, R., Ruz, M., Krone, E., Brice, M., Berjonneau, E., Matos, S., Dialla, O., & Guéroult-Accolas, L. (2026). Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journey. Future Oncology. https://doi.org/10.1080/14796694.2026.2666390

Source records

crossref · retrieved 2026-09-26T01:51:58.070Z